Sam Altman’s Merge Labs Explores Gene Therapy for Brain-AI Interface

Sam Altman’s Merge Labs Explores Gene Therapy for Brain-AI Interface

Sam Altman is backing Merge Labs, a new brain-computer interface venture exploring a gene therapy approach to connect human brains with AI. The company is considering genetically modifying brain cells to respond to ultrasound, enabling a less invasive implant system. Merge is currently raising $250 million at an $850 million valuation, with major backing expected from OpenAI’s venture arm. This move positions Altman in direct competition with Elon Musk’s Neuralink, which uses electrode-based implants. Merge’s approach combines sonogenetics and embedded ultrasound hardware, aiming for high-bandwidth communication between thought and AI systems. Altman is co-founding the project but won’t take a day-to-day role or personally invest.

Tämä jakso on lisätty Podme-palveluun avoimen RSS-syötteen kautta eikä se ole Podmen omaa tuotantoa. Siksi jakso saattaa sisältää mainontaa.

Jaksot(1452)

Can SpaceX catch a Starship Falling From Orbit

Can SpaceX catch a Starship Falling From Orbit

During Flight 13, the Starship upper stage achieved a successful soft splashdown, validating its thermal protection system, while the Super Heavy booster experienced a hard impact due to engine religh...

9 Elo 23min

Google Just Reshuffled the Team Building Its AI Future

Google Just Reshuffled the Team Building Its AI Future

Google is reorganizing DeepMind leadership as Demis Hassabis moves into a chairman role and other senior AI leaders depart to launch a new venture.In this episode, we look at what happens when a compa...

8 Elo 27min

SpaceX’s AI Spending Just Spooked Wall Street

SpaceX’s AI Spending Just Spooked Wall Street

SpaceX delivered a blockbuster first earnings report, with quarterly revenue up sharply and Starlink driving much of the growth. But investors focused on a much bigger number: the company’s enormous A...

7 Elo 21min

Eli Lilly’s Weight-Loss Boom Is Rewriting Big Pharma

Eli Lilly’s Weight-Loss Boom Is Rewriting Big Pharma

Eli Lilly raised its full-year outlook after strong demand for its diabetes and obesity treatments drove a major jump in revenue and profit.In this episode, we look at how GLP-1 drugs have become one ...

7 Elo 13min

Disney and TikTok Are Rewriting the Streaming Playbook

Disney and TikTok Are Rewriting the Streaming Playbook

Disney reported higher revenue, stronger streaming profits, and continued momentum from its parks and cruise business. Then it added an unexpected twist: a new partnership with TikTok designed to brin...

6 Elo 29min

Disney’s $1.2 Billion Exit Signals the End of an Old Media Era

Disney’s $1.2 Billion Exit Signals the End of an Old Media Era

Disney has agreed to sell its stake in A+E Global Media to Hearst, giving Hearst full ownership of brands including A&E, History, and Lifetime. The move reflects Disney’s effort to reduce its exposure...

6 Elo 17min

AMD’s AI Growth Is Exploding, So Why Are Investors Still Nervous?

AMD’s AI Growth Is Exploding, So Why Are Investors Still Nervous?

AMD posted a major jump in quarterly sales, with its data-center business growing especially quickly. Yet the market still pushed back after the company’s outlook failed to clear the very high expecta...

5 Elo 16min

Why six million people want MySpace back

Why six million people want MySpace back

The owners of MySpace, Chris and Tim Vanderhook, have confirmed plans to relaunch the iconic social media platform, sparking widespread discussion among users and industry experts. This potential come...

5 Elo 24min